Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Avacincaptad Pegol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aviceda Announces Phase 2b SIGLEC Results in Geographic Atrophy
    Aviceda Announces Phase 2b SIGLEC Results in Geographic Atrophy

    15 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251215245453/en/Aviceda-Therapeutics-Announces-Phase-2b-SIGLEC-Results-for-AVD-104-in-Geographic-Atrophy

    BUSINESSWIRE
    15 Dec 2025
    Share Share
    Astellas, Grandma Babs Partner to Raise Awareness on GA
    Astellas, Grandma Babs Partner to Raise Awareness on GA

    23 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/astellas-and-the-internets-favorite-grandma-barbara-babs-costello-partner-to-encourage-others-to-get-ahead-of-geographic-atrophy-ga-302591850.html

    PR NEWSWIRE
    23 Oct 2025
    Share Share
    Astellas To Unveil IZERVAY Data In Geographic Atrophy At AAO
    Astellas To Unveil IZERVAY Data In Geographic Atrophy At AAO

    08 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/astellas-to-present-new-data-on-izervay-avacincaptad-pegol-intravitreal-solution-in-geographic-atrophy-at-aao-2025-annual-meeting-302579011.html

    PR NEWSWIRE
    08 Oct 2025
    Share Share
    With Sales Turnaround, Astellas Projects Big Growth for Izervay
    With Sales Turnaround, Astellas Projects Big Growth for Izervay

    10 Jul 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/astellas-reports-22-sales-bump-izervay-projects-trend-continue-year

    FIERCE PHARMA
    10 Jul 2025
    Share Share
    Astellas to Present New Data in Geographic Atrophy
    Astellas to Present New Data in Geographic Atrophy

    01 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/astellas-to-present-new-data-in-geographic-atrophy-at-upcoming-ophthalmology-annual-congresses-302443334.html

    PR NEWSWIRE
    01 May 2025
    Share Share
    FDA Expands Label For Astellas’ IZERVAY In Geographic Atrophy
    FDA Expands Label For Astellas’ IZERVAY In Geographic Atrophy

    12 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/us-fda-approves-expanded-label-for-astellas-izervay-avacincaptad-pegol-intravitreal-solution-for-geographic-atrophy-302375403.html

    PR NEWSWIRE
    12 Feb 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.